Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Managing job execution
Resin composition and molded article
Wireless communication system using pilot allocation, method and pilot pattern thereof
Mobile target system
Intraoral camera for dental chairs
Isolated Australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development
Image enhancement based on multiple frames and motion estimation
  Randomly Featured Patents
Top rail for a refrigerated freight container
Nut cracker
Speakerphone with a novel loudspeaker placement
Active matrix substrate
Liquid crystal apparatus
Outlet box with removable self-contained device
Capacitive moisture sensor
Method and apparatus for inspecting or measuring a sample based on charged-particle beam imaging, and a charged-particle beam apparatus
Electronic control apparatus for failure diagnosis
Guzmania plant named Limbo